Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.
<h4>Background</h4>Posttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonstrated efficacy in treating chronic PTSD, a substantial proportion of patients still continue to meet PTSD criteria after treatment, h...
Saved in:
Main Authors: | Shakila Meshkat, Richard J Zeifman, Kathleen Stewart, Reinhard Janssen-Aguilar, Wendy Lou, Rakesh Jetly, Candice M Monson, Venkat Bhat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0313741 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01) -
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01) -
Posttraumatic Cortical Defect of Femur
by: Jeyaseelan Nadarajah, et al.
Published: (2013-01-01) -
Pharmacotherapy of Posttraumatic Cognitive Impairments
by: David B. Arciniegas, et al.
Published: (2006-01-01) -
Posttraumatic Cranial Cystic Fibrous Dysplasia
by: Arata Tomiyama, et al.
Published: (2011-01-01)